SCHEMBL14996505

SCHEMBL14996505

Cc1cc(N2CCC3(CCN(C)C3)CC2)cc(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 7/20 0.43
▸ ACVR1 Q04771 1/20 0.40
▸ LRRK2 Q5S007 1/20 0.39
▸ SPR P35270 1/20 0.37
▸ TMEM97 Q5BJF2 1/20 0.36
▸ SOS1 Q07889 1/20 0.36
▸ USP2 O75604 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14996508 0.81 PRDM9 (0.42) OGAACVR1LRRK2TMEM97SOS1
SCHEMBL13131064 0.81 OGA (0.42) OGAACVR1LRRK2TMEM97TSHR
SCHEMBL13168164 0.80 OGA (0.52) OGALRRK2TMEM97TSHRFFAR4
SCHEMBL13173967 0.76 KDM4E (0.53) KDM4ENPC1RAB9ASMN1; SMN2MEN1
SCHEMBL20468836 0.75 OGA (0.48) OGALRRK2USP2CYP2D6TSHR
SCHEMBL14996530 0.75 CYP2C9 (0.56) USP2CYP2D6CYP2C9TSHRHSD17B10
SCHEMBL13131255 0.74 SLC6A2 (0.48) OGASOS1USP2CYP2D6TSHR
Hydrochloric Acid SCHEMBL486277 0.73 SLC6A2 (0.47) OGASOS1USP2CYP2D6TSHR
SCHEMBL21711134 0.72 ALDH1A1 (0.50) OGALRRK2USP2CYP2D6CYP2C9
SCHEMBL20468827 0.72 ALDH1A1 (0.50) OGALRRK2USP2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 — — US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN OGA 3406/4885ACVR1 662/4885LRRK2 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback